-
1
-
-
33947403618
-
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration
-
Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol. 2007;143:566-583.
-
(2007)
Am J Ophthalmol.
, vol.143
, pp. 566-583
-
-
Fung, A.E.1
Lalwani, G.A.2
Rosenfeld, P.J.3
-
2
-
-
43249112791
-
Activity of neovascular lesions treated with bevacizumab: Comparison between optical coherence tomography and fluorescein angiography
-
Krebs I, Ansari-Shahrezaei S, Goll A, Binder S. Activity of neovascular lesions treated with bevacizumab: comparison between optical coherence tomography and fluorescein angiography. Graefes Arch Clin Exp Ophthalmol. 2008;246:811-815.
-
(2008)
Graefes Arch Clin Exp Ophthalmol.
, vol.246
, pp. 811-815
-
-
Krebs, I.1
Ansari-Shahrezaei, S.2
Goll, A.3
Binder, S.4
-
3
-
-
70349576361
-
Correlation of highdefinition optical coherence tomography and fluorescein angiography imaging in neovascular macular degeneration
-
Malamos P, Sacu S, Georgopoulos M, et al. Correlation of highdefinition optical coherence tomography and fluorescein angiography imaging in neovascular macular degeneration. Invest Ophthalmol Vis Sci. 2009;50:4926-4933.
-
(2009)
Invest Ophthalmol Vis Sci.
, vol.50
, pp. 4926-4933
-
-
Malamos, P.1
Sacu, S.2
Georgopoulos, M.3
-
4
-
-
34247562266
-
VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group, Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration
-
Chakravarthy U, Adamis AP, Cunningham ET, et al. VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group, Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. Ophthalmology. 2006;113:1508. e1-25.
-
(2006)
Ophthalmology.
, vol.113
-
-
Chakravarthy, U.1
Adamis, A.P.2
Cunningham, E.T.3
-
5
-
-
33749445317
-
Ranibizumab for neovascular age-related macular degeneration
-
MARINA Study Group
-
Rosenfeld PJ, Brown DM, Heier JS, Boyer, et al.; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419-1431.
-
(2006)
N Engl J Med.
, vol.355
, pp. 1419-1431
-
-
Rosenfeld, P.J.1
Brown, D.M.2
Heier, J.S.3
Boyer4
-
6
-
-
36249002808
-
Ranibizumab for predominantly classic neovascular age-related macular degeneration: Subgroup analysis of first-year ANCHOR results
-
Kaiser PK, Brown DM, Zhang K, et al. Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol. 2007;144:850-857.
-
(2007)
Am J Ophthalmol.
, vol.144
, pp. 850-857
-
-
Kaiser, P.K.1
Brown, D.M.2
Zhang, K.3
-
7
-
-
78651369035
-
Reproducibility and comparison of retinal thickness and volume measurements in normal eyes determined with two different Cirrus OCT scanning protocols
-
Hagen S, Krebs I, Haas P, et al. Reproducibility and comparison of retinal thickness and volume measurements in normal eyes determined with two different Cirrus OCT scanning protocols. Retina. 2011;31:41-47.
-
(2011)
Retina.
, vol.31
, pp. 41-47
-
-
Hagen, S.1
Krebs, I.2
Haas, P.3
-
8
-
-
56149108242
-
Comparison of macular thickness measurements between time domain and spectral domain optical coherence tomography
-
Leung CK, Cheung CY, Weinreb RN, et al. Comparison of macular thickness measurements between time domain and spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2008;49:4893-4897.
-
(2008)
Invest Ophthalmol Vis Sci.
, vol.49
, pp. 4893-4897
-
-
Leung, C.K.1
Cheung, C.Y.2
Weinreb, R.N.3
-
9
-
-
67649946247
-
Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments
-
Wolf-Schnurrbusch UE, Ceklic L, Brinkmann CK, et al. Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci. 2009;50:3432-3437.
-
(2009)
Invest Ophthalmol Vis Sci.
, vol.50
, pp. 3432-3437
-
-
Wolf-Schnurrbusch, U.E.1
Ceklic, L.2
Brinkmann, C.K.3
-
10
-
-
78549278047
-
Cirrus OCT versus Spectralis OCT: Differences in segmentation in fibrovascular pigment epithelial detachment
-
Smretschnig E, Krebs I, Moussa S, Ansari-Shahrezaei S, Binder S. Cirrus OCT versus Spectralis OCT: differences in segmentation in fibrovascular pigment epithelial detachment. Graefes Arch Clin Exp Ophthalmol. 2010;248:1693-1698.
-
(2010)
Graefes Arch Clin Exp Ophthalmol.
, vol.248
, pp. 1693-1698
-
-
Smretschnig, E.1
Krebs, I.2
Moussa, S.3
Ansari-Shahrezaei, S.4
Binder, S.5
-
11
-
-
31644448419
-
Errors in retinal thickness measurements obtained by optical coherence tomography
-
Sadda SR, Wu Z, Walsh AC, et al. Errors in retinal thickness measurements obtained by optical coherence tomography. Ophthalmology. 2006;113:285-293.
-
(2006)
Ophthalmology.
, vol.113
, pp. 285-293
-
-
Sadda, S.R.1
Wu, Z.2
Walsh, A.C.3
-
12
-
-
77952892012
-
Evaluation of artifacts associated with macular spectral-domain optical coherence tomography
-
Han IC, Jaffe GJ. Evaluation of artifacts associated with macular spectral-domain optical coherence tomography. Ophthalmology. 2010;117(6):1177-1189.
-
(2010)
Ophthalmology.
, vol.117
, Issue.6
, pp. 1177-1189
-
-
Han, I.C.1
Jaffe, G.J.2
-
13
-
-
77955472340
-
Repeatability and reproducibility of retinal thickness measurements by optical coherence tomography in age-related macular degeneration
-
Krebs I, Hagen S, Brannath W, et al. Repeatability and reproducibility of retinal thickness measurements by optical coherence tomography in age-related macular degeneration. Ophthalmology. 2010;117(8):1577-1584.
-
(2010)
Ophthalmology.
, vol.117
, Issue.8
, pp. 1577-1584
-
-
Krebs, I.1
Hagen, S.2
Brannath, W.3
-
14
-
-
77955500358
-
Macular thickness interoperator and intraoperator reproducibility in healthy eyes using 7 optical coherence tomography instruments
-
Pierro L, Giatsidis SM, Mantovani E, Gagliardi M. Macular thickness interoperator and intraoperator reproducibility in healthy eyes using 7 optical coherence tomography instruments. Am J Ophthalmol. 2010;150:199-204.
-
(2010)
Am J Ophthalmol.
, vol.150
, pp. 199-204
-
-
Pierro, L.1
Giatsidis, S.M.2
Mantovani, E.3
Gagliardi, M.4
-
15
-
-
77957375463
-
Reproducibility of macular thickness measurements using Cirrus spectral domain optical coherence tomography in neovascular age-related macular degeneration
-
Parravano M, Oddone F, Boccassini B, et al. Reproducibility of macular thickness measurements using Cirrus spectral domain optical coherence tomography in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2010;51(9):4788-4791.
-
(2010)
Invest Ophthalmol Vis Sci.
, vol.51
, Issue.9
, pp. 4788-4791
-
-
Parravano, M.1
Oddone, F.2
Boccassini, B.3
-
16
-
-
70349440977
-
Assessment of artifacts and reproducibility across spectral-and time-domain optical coherence tomography systems
-
Ho J, Sull AC, Vuong LN, et al. Assessment of artifacts and reproducibility across spectral-and time-domain optical coherence tomography systems. Ophthalmology. 2009;116:1960-1970.
-
(2009)
Ophthalmology.
, vol.116
, pp. 1960-1970
-
-
Ho, J.1
Sull, A.C.2
Vuong, L.N.3
-
17
-
-
77449124203
-
Impact of scanning density on measurements from spectral domain optical coherence tomography
-
Sadda SR, Keane PA, Ouyang Y, Updike JF, Walsh AC. Impact of scanning density on measurements from spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2010;51: 1071-1078.
-
(2010)
Invest Ophthalmol Vis Sci.
, vol.51
, pp. 1071-1078
-
-
Sadda, S.R.1
Keane, P.A.2
Ouyang, Y.3
Updike, J.F.4
Walsh, A.C.5
-
18
-
-
62649101218
-
Quality of the threshold algorithm in age-related macular degeneration: Stratus versus Cirrus OCT
-
Krebs I, Falkner-Radler C, Hagen S, et al. Quality of the threshold algorithm in age-related macular degeneration: Stratus versus Cirrus OCT. Invest Ophthalmol Vis Sci. 2009;50:995-1000.
-
(2009)
Invest Ophthalmol Vis Sci.
, vol.50
, pp. 995-1000
-
-
Krebs, I.1
Falkner-Radler, C.2
Hagen, S.3
-
19
-
-
70350440496
-
Comparison of retinal thickness measurements and segmentation performance of four different spectral and time domain OCT systems in neovascular age-related macular degeneration
-
Mylonas G, Ahlers C, Malamos P, et al. Comparison of retinal thickness measurements and segmentation performance of four different spectral and time domain OCT systems in neovascular age-related macular degeneration. Br J Ophthalmol. 2009;93(11): 1453-1460.
-
(2009)
Br J Ophthalmol.
, vol.93
, Issue.11
, pp. 1453-1460
-
-
Mylonas, G.1
Ahlers, C.2
Malamos, P.3
-
20
-
-
47049106131
-
Optical coherence tomography: Limits of the retinal-mapping program in age-related macular degeneration
-
Krebs I, Haas P, Zeiler F, Binder S. Optical coherence tomography: limits of the retinal-mapping program in age-related macular degeneration. Br J Ophthalmol. 2008;92(7):933-935.
-
(2008)
Br J Ophthalmol.
, vol.92
, Issue.7
, pp. 933-935
-
-
Krebs, I.1
Haas, P.2
Zeiler, F.3
Binder, S.4
-
21
-
-
77955896110
-
Clinical assessment of mirror artifacts in spectral-domain optical coherence tomography
-
Ho J, Castro DP, Castro LC, et al. Clinical assessment of mirror artifacts in spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2010;51:3714-3720.
-
(2010)
Invest Ophthalmol Vis Sci.
, vol.51
, pp. 3714-3720
-
-
Ho, J.1
Castro, D.P.2
Castro, L.C.3
-
22
-
-
80054951982
-
Conversion of Stratus optical coherence tomography (OCT) retinal thickness to Cirrus OCT values in age-related macular degeneration
-
Published online February 24
-
Krebs I, Hagen S, Smretschnig E, Womastek I, Brannath W, Binder S. Conversion of Stratus optical coherence tomography (OCT) retinal thickness to Cirrus OCT values in age-related macular degeneration. Br J Ophthalmol. Published online February 24, 2011.
-
(2011)
Br J Ophthalmol.
-
-
Krebs, I.1
Hagen, S.2
Smretschnig, E.3
Womastek, I.4
Brannath, W.5
Binder, S.6
|